Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILOT study of Retaane (anecortave acetate) in choroidal neovascularization due to age-related macular degeneration
2005-001971-36Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anecortave in Age-related macular degeneration (AMD), sponsored by IRCCS Ospedale San Raffaele. Started Sep 2005; status: completed.
02
Drugs
anecortave
03
Conditions
Age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2005-001971-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001971-36.